
Glivir-MV1 Tablet SR
Marketer
Viribus Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glivir-MV1 Tablet SR
DiabetaComb SR tablets are classified as antidiabetic medications, a combination therapy for adult-onset type 2 diabetes. They help manage blood glucose. DiabetaComb SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial; discontinuation without medical consultation can elevate blood sugar, risking kidney complications, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Prompt glucose intake (sugary foods or juice) is essential. Alcohol should be avoided due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood counts, liver function) are recommended.
Primary Ingredients of Glivir-MV1 Tablet SR
No information provided. Please provide the text you wish to be rewritten.
Uses of Glivir-MV1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glivir-MV1 Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Glivir-MV1 Tablet SR whole; avoid chewing, crushing, or fracturing. Consumption should occur on an empty stomach.
Common Side effects of Glivir-MV1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glivir-MV1 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Glivir-MV1 Tablet SR should be administered on an empty stomach.
How Glivir-MV1 Tablet SR works:
Glivir-MV1 Extended-Release Tablets contain a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glivir-MV1 Tablet SR with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glivir-MV1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Consult your doctor for guidance.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glivir-MV1 tablet is likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glivir-MV1 Tablet SR is inadvisable for individuals with kidney impairment and should be avoided. Patients with severe kidney disease are especially cautioned against its use; medical consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Glivir-MV1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically prescribed for those with mild to moderate hepatic dysfunction; the medication is contraindicated in patients with severe liver disease.
What if you forget to take Glivir-MV1 Tablet SR :
Should you forget a Glivir-MV1 Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glivir-MV1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
